Neuroleptic Malignant Syndrome: The Value of Diagnostic Criteria

Prim Care Companion CNS Disord. 2018 Aug 2;20(4):17l02218. doi: 10.4088/PCC.17l02218.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Male
  • Neuroleptic Malignant Syndrome / diagnosis*
  • Neuroleptic Malignant Syndrome / therapy

Substances

  • Antipsychotic Agents